Cogent Biosciences Statistics
Total Valuation
COGT has a market cap or net worth of $6.00 billion. The enterprise value is $5.34 billion.
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COGT has 161.05 million shares outstanding. The number of shares has increased by 24.09% in one year.
| Current Share Class | 160.98M |
| Shares Outstanding | 161.05M |
| Shares Change (YoY) | +24.09% |
| Shares Change (QoQ) | +9.05% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 105.75% |
| Float | 150.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 10.97 |
| P/TBV Ratio | 10.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.23, with a Debt / Equity ratio of 0.38.
| Current Ratio | 14.23 |
| Quick Ratio | 14.08 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -108.87 |
Financial Efficiency
Return on equity (ROE) is -73.70% and return on invested capital (ROIC) is -36.27%.
| Return on Equity (ROE) | -73.70% |
| Return on Assets (ROA) | -32.93% |
| Return on Invested Capital (ROIC) | -36.27% |
| Return on Capital Employed (ROCE) | -38.16% |
| Weighted Average Cost of Capital (WACC) | 6.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.27M |
| Employee Count | 258 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +772.37% in the last 52 weeks. The beta is 0.47, so COGT's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +772.37% |
| 50-Day Moving Average | 36.68 |
| 200-Day Moving Average | 26.19 |
| Relative Strength Index (RSI) | 54.59 |
| Average Volume (20 Days) | 2,640,195 |
Short Selling Information
The latest short interest is 17.43 million, so 10.82% of the outstanding shares have been sold short.
| Short Interest | 17.43M |
| Short Previous Month | 15.60M |
| Short % of Shares Out | 10.82% |
| Short % of Float | 11.54% |
| Short Ratio (days to cover) | 7.99 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -333.36M |
| Pretax Income | -328.94M |
| Net Income | -328.94M |
| EBITDA | -330.80M |
| EBIT | -333.36M |
| Earnings Per Share (EPS) | -$2.55 |
Full Income StatementBalance Sheet
The company has $900.77 million in cash and $238.80 million in debt, with a net cash position of $661.97 million or $4.11 per share.
| Cash & Cash Equivalents | 900.77M |
| Total Debt | 238.80M |
| Net Cash | 661.97M |
| Net Cash Per Share | $4.11 |
| Equity (Book Value) | 636.37M |
| Book Value Per Share | 3.40 |
| Working Capital | 846.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$264.44 million and capital expenditures -$1.55 million, giving a free cash flow of -$266.00 million.
| Operating Cash Flow | -264.44M |
| Capital Expenditures | -1.55M |
| Depreciation & Amortization | 2.56M |
| Net Borrowing | 217.76M |
| Free Cash Flow | -266.00M |
| FCF Per Share | -$1.65 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COGT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.09% |
| Shareholder Yield | n/a |
| Earnings Yield | -5.48% |
| FCF Yield | -4.43% |
Analyst Forecast
The average price target for COGT is $36.21, which is -2.79% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.21 |
| Price Target Difference | -2.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 9, 2020. It was a reverse split with a ratio of 1:4.
| Last Split Date | Nov 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
